SMMT icon

Summit Therapeutics

55 hedge funds and large institutions have $13.6M invested in Summit Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

20% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 20

42% less capital invested

Capital invested by funds: $23.3M → $13.6M (-$9.7M)

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$135K
Puts
$51K
Net Calls
Net Calls Change

Top Buyers

1 +$538K
2 +$348K
3 +$216K
4
Citadel Advisors
Citadel Advisors
Florida
+$115K
5
TSS
Two Sigma Securities
New York
+$52K

Top Sellers

1 -$249K
2 -$146K
3 -$72K
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
-$40.7K
5
SG Americas Securities
SG Americas Securities
New York
-$28.3K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.77M
2
$2.44M
3
$1.17M
4
$963K
5
$907K
6
$669K
7
$582K
8
$518K
9
$313K
10
$303K
11
$227K
12
$149K
13
$134K
14
$126K
15
$119K
16
$115K
17
$90K
18
$59K
19
$52K
20
$52K
21
$52K
22
$46K
23
$46K
24
$43K
25
$42K